261 related articles for article (PubMed ID: 1823309)
21. Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.
Semana G; Allanic H; Quillivic F; Vallejo MT; Simon JP; Genetet B; Fauchet R
Hum Immunol; 1990 Oct; 29(2):143-9. PubMed ID: 1979072
[TBL] [Abstract][Full Text] [Related]
22. [Class 1 and 2 HLA in coeliacia patients in Belarus].
Gorgun IuV; Semenov GV; Portianko AS
Klin Med (Mosk); 2010; 88(3):35-40. PubMed ID: 20608062
[TBL] [Abstract][Full Text] [Related]
23. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
24. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.
Luongo V; Pirozzi G; Caracò C; Errico S; de Angelis F; Celentano E; Paino F; Chiofalo MG; Luongo M; Mozzillo N; Lombardi ML
Tissue Antigens; 2004 Jul; 64(1):84-7. PubMed ID: 15191529
[TBL] [Abstract][Full Text] [Related]
25. HLA class II distribution in Congolese with hyperthyroidism: preliminary results.
Bidingija M; Galgani A; Buzzetti R; Ditu M
Ann Endocrinol (Paris); 2006 Dec; 67(6):596-603. PubMed ID: 17194971
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of HLA genetic factors in IDDM susceptibility.
Martell M; Marcadet A; Moine A; Boitard C; Deschamps I; Dausset J; Bach JF; Cohen D
Immunogenetics; 1990; 31(4):233-40. PubMed ID: 1970333
[TBL] [Abstract][Full Text] [Related]
27. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.
Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R
Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242
[TBL] [Abstract][Full Text] [Related]
28. A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility.
Carcassi C; Trucco G; Trucco M; Contu L
Hum Immunol; 1991 Jul; 31(3):159-64. PubMed ID: 1890017
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of HLA DQB1 CAR1/CAR2 and TNFalpha IR2/IR4 microsatellite markers in patients affected with Graves disease.
Maalej A; Hadj Kacem H; Bellassoued M; Abid M; Makni H; Ayadi H
Clin Immunol; 2000 Aug; 96(2):91-3. PubMed ID: 10900155
[TBL] [Abstract][Full Text] [Related]
30. HLA antigen frequencies in children born to HIV-infected mothers.
Kilpatrick DC; Hague RA; Yap PL; Mok JY
Dis Markers; 1991; 9(1):21-6. PubMed ID: 1742942
[TBL] [Abstract][Full Text] [Related]
31. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects.
Cavan DA; Penny MA; Jacobs KH; Kelly MA; Jenkins D; Mijovic C; Chow C; Cockram CS; Hawkins BR; Barnett AH
Clin Endocrinol (Oxf); 1994 Jan; 40(1):63-6. PubMed ID: 8306482
[TBL] [Abstract][Full Text] [Related]
32. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy.
Akaishi PM; Cruz AA; Silva FL; Rodrigues Mde L; Maciel LM; Donadi EA
Thyroid; 2008 Apr; 18(4):443-7. PubMed ID: 18352820
[TBL] [Abstract][Full Text] [Related]
33. The absence of 21-OH A and C4 B genes is a constant characteristic of the "Sardinian" HLA extended haplotype A30 Cw5 B18 BfF1 DR3 DRw52 DQw2.
Carcassi C; Porcella R; Manca ML; Orrù S; La Nasa G; Contu L
Tissue Antigens; 1989 Aug; 34(2):85-9. PubMed ID: 2609326
[TBL] [Abstract][Full Text] [Related]
34. The genetics of Graves' disease: HLA and disease susceptibility.
Stenszky V; Kozma L; Balázs C; Rochlitz S; Bear JC; Farid NR
J Clin Endocrinol Metab; 1985 Oct; 61(4):735-40. PubMed ID: 3861611
[TBL] [Abstract][Full Text] [Related]
35. HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians.
Mercier P; Vallo JJ; Vialettes B; Vague P
Tissue Antigens; 1985 Jul; 26(1):20-4. PubMed ID: 3875911
[TBL] [Abstract][Full Text] [Related]
36. HLA and Graves' disease: an association with HLA-DRw3.
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
[TBL] [Abstract][Full Text] [Related]
37. The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication?
Contu L; Carcassi C; Dausset J
Immunogenetics; 1989; 30(1):13-7. PubMed ID: 2744807
[TBL] [Abstract][Full Text] [Related]
38. Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women.
Barlow AB; Wheatcroft N; Watson P; Weetman AP
Clin Endocrinol (Oxf); 1996 Jan; 44(1):73-7. PubMed ID: 8706297
[TBL] [Abstract][Full Text] [Related]
39. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
[TBL] [Abstract][Full Text] [Related]
40. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
